Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 02-2021 | 11-2020 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 6,746 | 682 |
| Receivables | 323 | 11 |
| TOTAL | $7,557 | $836 |
| Non-Current Assets | ||
| Intangibles | 17 | 973 |
| Other Non-Current Assets | 0 | 199 |
| TOTAL | $17 | $1,172 |
| Total Assets | $7,574 | $2,008 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 88 | 334 |
| TOTAL | $106 | $392 |
| Non-Current Liabilities | ||
| TOTAL | $0 | $0 |
| Total Liabilities | $106 | $392 |
| Shareholders' Equity | ||
| Common Shares | 9,834 | 2,400 |
| Retained earnings | -3,336 | -946 |
| TOTAL | $7,468 | $1,616 |
| Total Liabilities And Equity | $7,574 | $2,008 |